CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 157 filers reported holding CARA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $112,595 | -48.7% | 67,021 | -13.7% | 0.00% | – |
| Q2 2023 | $219,659 | -28.5% | 77,618 | +24.1% | 0.00% | – |
| Q1 2023 | $307,062 | +118.1% | 62,538 | +377.1% | 0.00% | – |
| Q4 2022 | $140,791 | -100.0% | 13,109 | -62.8% | 0.00% | -100.0% |
| Q3 2022 | $329,640,000 | +58.6% | 35,218 | +54.7% | 0.00% | – |
| Q2 2022 | $207,799,000 | -48.4% | 22,760 | -31.3% | 0.00% | -100.0% |
| Q1 2022 | $402,554,000 | -9.0% | 33,132 | -8.8% | 0.00% | 0.0% |
| Q4 2021 | $442,378,000 | -48.4% | 36,320 | -34.6% | 0.00% | 0.0% |
| Q3 2021 | $857,614,000 | +90.8% | 55,509 | +76.2% | 0.00% | 0.0% |
| Q2 2021 | $449,562,000 | +26.5% | 31,504 | +92.5% | 0.00% | 0.0% |
| Q1 2021 | $355,262,000 | +81.6% | 16,364 | +26.6% | 0.00% | – |
| Q4 2020 | $195,586,000 | +60.7% | 12,927 | +35.1% | 0.00% | – |
| Q3 2020 | $121,740,000 | +382.3% | 9,567 | +548.2% | 0.00% | – |
| Q2 2020 | $25,240,000 | -84.6% | 1,476 | -88.1% | 0.00% | – |
| Q1 2020 | $163,527,000 | +115.4% | 12,379 | +162.7% | 0.00% | – |
| Q4 2019 | $75,910,000 | -30.3% | 4,712 | -20.9% | 0.00% | – |
| Q3 2019 | $108,857,000 | +39.2% | 5,955 | +63.7% | 0.00% | – |
| Q2 2019 | $78,196,000 | -41.2% | 3,637 | -46.3% | 0.00% | – |
| Q1 2019 | $132,984,000 | +102195.4% | 6,778 | +67680.0% | 0.00% | – |
| Q4 2018 | $130,000 | -99.4% | 10 | -98.9% | 0.00% | – |
| Q3 2018 | $21,124,000 | +14.3% | 882 | -8.6% | 0.00% | – |
| Q2 2018 | $18,480,000 | -73.8% | 965 | -83.1% | 0.00% | – |
| Q1 2018 | $70,541,000 | +4.8% | 5,698 | +3.6% | 0.00% | – |
| Q4 2017 | $67,296,000 | +114.2% | 5,498 | +139.6% | 0.00% | – |
| Q3 2017 | $31,419,000 | -16.7% | 2,295 | -6.4% | 0.00% | – |
| Q2 2017 | $37,721,000 | +9213.8% | 2,451 | +11040.9% | 0.00% | – |
| Q1 2017 | $405,000 | -72.6% | 22 | -86.2% | 0.00% | – |
| Q4 2016 | $1,477,000 | -87.2% | 159 | -88.5% | 0.00% | – |
| Q3 2016 | $11,573,000 | +205.0% | 1,386 | +75.7% | 0.00% | – |
| Q2 2016 | $3,795,000 | -94.1% | 789 | -79.5% | 0.00% | – |
| Q4 2015 | $64,742,000 | +13.3% | 3,840 | -4.0% | 0.00% | – |
| Q3 2015 | $57,131,000 | +238.5% | 3,998 | +187.8% | 0.00% | – |
| Q2 2015 | $16,876,000 | +1162.2% | 1,389 | +944.4% | 0.00% | – |
| Q1 2015 | $1,337,000 | +34.0% | 133 | +11.8% | 0.00% | – |
| Q3 2014 | $998,000 | -80.2% | 119 | -59.8% | 0.00% | – |
| Q2 2014 | $5,038,000 | – | 296 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
| Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
| Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
| DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
| Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
| Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
| Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |